Document is current
Any future updates will be listed below
-
Authors
Hunter, Miranda V. https://orcid.org/0000-0002-6971-1738
Moncada, Reuben
Weiss, Joshua M.
Yanai, Itai
White, Richard M. https://orcid.org/0000-0001-9099-9169
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | National Institutes of Health (R01CA229215, R01CA238317, DP2CA186572)
U.S. Department of Health & Human Services | National Institutes of Health
U.S. Department of Health & Human Services | National Institutes of Health
Pershing Square Foundation
Harry J. Lloyd Charitable Trust
- License Information
-
More Information
Article History
Received: 7 December 2020
Accepted: 6 October 2021
First Online: 1 November 2021
Competing interests
: R.M.W. is a paid consultant to N-of-One Therapeutics, a subsidiary of Qiagen. R.M.W. is on the scientific advisory board of Consano, but receives no income for this. R.M.W. receives royalty payments for the use of the <i>casper</i> zebrafish line from Carolina Biologicals. M.V.H., R.M., J.M.W., and I.Y. declare no competing interests.
